NUTX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Nutex Health Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit!

NEW YORK CITY, NY / ACCESS Newswire / October 17, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Nutex Health Inc. ("Nutex" or "the Company") (NASDAQ:NUTX) and certain of its officers. Class Definition This lawsuit seeks to recover damages against […]

FLYE SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Fly-E Group, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

NEW YORK CITY, NY / ACCESS Newswire / October 17, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Fly-E Group, Inc. ("Fly-E" or "the Company") (NASDAQ:FLYE) and certain of its officers. Class Definition This lawsuit seeks to recover damages against

MLTX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that MoonLake Immunotherapeutics Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

NEW YORK CITY, NY / ACCESS Newswire / October 17, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against MoonLake Immunotherapeutics ("MoonLake" or "the Company") (NASDAQ:MLTX) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants

Tilray Brands Marks Seven Years of Cannabis Legalization in Canada with the #1 Market-Leading Position by Revenue and Pioneering Brands with Growing Market Share in the World’s Largest Federally Legal Cannabis Market

(NASDAQ:TLRY),(TSX:TLRY), TORONTO, Oct. 17, 2025 (GLOBE NEWSWIRE) — Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the global cannabis, beverage, and wellness industries, proudly celebrates the seventh anniversary of cannabis legalization in Canada. As the largest federally legal cannabis market

Fabrinet Announces Retirement of Founder and Chairman Tom Mitchell After 25 Years of Visionary Leadership

(NYSE:FN), BANGKOK, Oct. 17, 2025 (GLOBE NEWSWIRE) — Fabrinet (NYSE: FN), a leading provider of advanced optical packaging and precision optical, electro-mechanical and electronic manufacturing services to original equipment manufacturers of complex products, today announced the retirement of company founder and Chairman, David T. (“Tom”) Mitchell, after 25 years of visionary leadership. Mr. Mitchell founded

XORTX Announces Acquisition of Renal Anti-Fibrotic Therapeutic Program from Vectus Biosystems

(TSX-V:XRTX),(NASDAQ:XRTX),(Boerse Frankfurt – Freiverkehr:ANUA.F), CALGARY, Alberta, Oct. 17, 2025 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“XORTX” or the “Company“) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical pharmaceutical company focused on developing innovative therapies to treat gout and progressive kidney disease, announces that it has entered into a binding term sheet

Sight Sciences Announces Fee Schedule Establishment from Novitas Solutions and First Coast Service Options for the TearCare(R) Interventional Dry Eye Procedure

(NASDAQ:SGHT), MENLO PARK, Calif., Oct. 17, 2025 (GLOBE NEWSWIRE) — Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to transform care and improve patients' lives, today announced that two Medicare Administrative Contractors (MACs), Novitas Solutions, Inc. (Novitas) and First Coast

Emerita Extends El Cura Deposit 90 Meters Westward, Intersecting 4.1 Meters Grading 3.9% copper, 3.6% lead 8.5% Zinc, 4.08 g/t gold and 96.4 g/t silver

(TSX-V:EMO),(OTC US:EMOTF),(Other OTC:EMOTF),(Frankfurt:LLJA), TORONTO, Oct. 17, 2025 (GLOBE NEWSWIRE) — Emerita Resources Corp. (TSX-V: EMO; OTCQB: EMOTF; FSE: LLJA) (the “Company” or “Emerita”) announces ongoing diamond drilling results that continue to intersect high grades and significantly expand the El Cura deposit. The latest drill hole (EC080) intercepted excellent grades and extends the mineralization at least

Eledon Pharmaceuticals to Present Results from Phase 2 BESTOW Trial of Tegoprubart for the Prevention of Rejection in Kidney Transplantation at the American Society of Nephrology Kidney Week 2025 Annual Meeting

(NASDAQ:ELDN), IRVINE, Calif., Oct. 17, 2025 (GLOBE NEWSWIRE) — Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN) today announced an oral presentation will be featured at the American Society of Nephrology's upcoming Kidney Week 2025 Annual Meeting taking place in Houston, TX, from November 5-8, 2025. The oral presentation will highlight topline results from the Phase 2

CfPA Announces 2025 Regulated Investment Crowdfunding Summit: Shaping the Future of Capital Formation

Washington, D.C., Oct. 17, 2025 (GLOBE NEWSWIRE) — The Crowdfunding Professional Association (CfPA) is pleased to announce the 2025 Regulated Investment Crowdfunding Industry and Leadership Summit, taking place October 21-22, 2025, at the National Union Building (918 F St NW, Washington, DC). Now in its second year welcoming national regulators and policymakers, the CfPA Summit

Scroll to Top